Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1061, pseudogene (RNU6-1061P) is a genomic sequence arising from a duplication of the *U6 small nuclear RNA* gene, but it has accumulated mutations or regulatory changes that prevent it from producing a functional RNA molecule[2][3][4][5]. Pseudogenes like RNU6-1061P are usually classified as **processed pseudogenes**, generated by the reverse transcription of mature RNA transcripts followed by genomic reintegration[3][5]. Although traditionally viewed as non-functional, recent genomic research indicates that some pseudogenes can have regulatory functions by influencing the expression of their parent or related genes, or by acting as sources of non-coding RNAs[3][4]. However, for RNU6-1061P specifically, there is no evidence of protein-coding or well-characterized biological function, and it is not used as a disease biomarker, therapeutic target, or drug-interaction partner. If your context requires information about functional small nuclear RNAs or their pseudogenes in disease or drug development, RNU6-1061P is best classified as a **noncanonical, nonfunctional genomic element**—one of many such loci in the genome[2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1061, pseudogene (RNU6-1061P).